Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Generale denteFRA:GD6 -0.46%71 EV-to-EBIT is 41.71 as of Jul. 25, 2026, which is 11% below its 10-year median of 46.67. GuruFocus rates FRA:GD6 with a GF Score™ of 71/100 and a GF Value™ of €21.83. The stock has 8 warning signs investors should review. Among 469 Healthcare Providers & Services companies, Ramsay Generale dente ranks worse than 84.86% on this metric.
The historical rank and industry rank for Ramsay Generale dente's EV-to-EBIT or its related term are showing as below:
FRA:GD6'
s EV-to-EBIT Range Over the Past 10 Years
Min: 41.71 Med: 46.67 Max: 98.48
Current: 41.71
During the past 13 years, the highest EV-to-EBIT of Ramsay Generale dente was 98.48. The lowest was 41.71. And the median was 46.67.
FRA:GD6's EV-to-EBIT is ranked worse than 84.86% of 469
companies
in the Healthcare Providers & Services industry
Industry Median: 15.87
vs FRA:GD6: 41.71
Ramsay Generale dente (FRA:GD6) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ramsay Generale dente's Enterprise Value for the quarter that ended in Dec. 2025 was €4,874 Mil.
Ramsay Generale dente's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €120 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ramsay Generale dente's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Generale dente EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ramsay Generale dente's EV-to-EBIT falls into.
Ramsay Generale dente's current Enterprise Value is €5,021 Mil.
Ramsay Generale dente's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €120 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente (FRA:GD6) has a EV-to-EBIT of 41.71 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ramsay Generale dente and its competitors. This is 11% below median its historical median of 46.67. Over the past decade, Ramsay Generale dente's EV-to-EBIT has ranged from 41.71 to 98.48. According to the industry distribution chart, Ramsay Generale dente ranks #398 out of 469 companies in the Healthcare Providers & Services industry, placing it in the top 84.9%.
Is Ramsay Generale dente's EV-to-EBIT too high?
Ramsay Generale dente's current EV-to-EBIT of 41.71 is 11% below median its 10-year median of 46.67. Over the past 10 years, this metric has ranged from a low of 41.71 to a high of 98.48. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. Ramsay Generale dente's value of 41.71 is 162.8% above this industry median. Based on the distribution chart, Ramsay Generale dente ranks #398 out of 469 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ramsay Generale dente has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Generale dente ranks #398 out of 469 companies for EV-to-EBIT. This places Ramsay Generale dente in the lower half of its industry. The industry median EV-to-EBIT is 15.87. Ramsay Generale dente's value of 41.71 is 162.8% above this benchmark. Historically, Ramsay Generale dente's own EV-to-EBIT has ranged from 41.71 to 98.48 over the past decade. While the company's 10-year median is 46.67 vs. the industry median of 15.87, Ramsay Generale dente has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Generale dente's current EV-to-EBIT of 41.71 is 162.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ramsay Generale dente and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Generale dente's current EV-to-EBIT is 41.71, which is 11% below median its own 10-year median of 46.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Ramsay Generale dente (FRA:GD6) has a current EV-to-EBIT of 41.71. The stock's GF Value™ is €21.83, compared to a current price of €10.75 — trading 50.8% below its estimated fair value. The current EV-to-EBIT is 41.71, which is 11% below median its 10-year median of 46.67 and 162.8% above the Healthcare Providers & Services industry median of 15.87. Ramsay Generale dente's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ramsay Generale dente (FRA:GD6), the current EV-to-EBIT is 41.71 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Generale dente (FRA:GD6) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued.
The current stock price of €10.75 is trading 50.8% below its estimated GF Value™ of €21.83.
Key valuation signals for FRA:GD6:
EV-to-EBIT: 41.71 (11% below median its 10-year median of 46.67)
GF Value™: €21.83 vs. price of €10.75 (50.8% below fair value)
Industry Position: 162.8% above the Healthcare Providers & Services median (#398 of 469)
No single metric tells the full story. See the FRA:GD6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score
Get the complete analysis for FRA:GD6
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GD6 has been successfully added to your 
